Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03523260
Other study ID # IRB-130430002
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date August 27, 2013
Est. completion date January 22, 2020

Study information

Verified date May 2021
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The patient population for this study is individuals requiring high-flow polyurethane tunneled dialysis catheters (TDC) for hemodialysis access. The primary objective of this study is to compare outcomes of participants who undergo left internal jugular placement of a split-tip versus a step-tip versus symmetric tip catheter. This study will review and compare the complication rate and function of the three catheter designs.


Description:

The patient population for this study is individuals requiring high-flow polyurethane tunneled dialysis catheters (TDC) for hemodialysis access. The primary objective of this study is to compare outcomes of participants who undergo left internal jugular placement of a split-tip versus a step-tip versus symmetric tip catheter. Participants will be randomized to receive a split-tip, step-tip or symmetric tip catheter in a 1:1:1 ratio. All participants will be followed per their referring physician's standard of care. Information regarding any patient complications will be obtained from Dr. Allon's dialysis patient database (Vascular Access in Hemodialysis Patients, IRB # X980813005). This study will review and compare the complication rate and function of the three catheter designs. There are no studies to our knowledge that compared catheter designs placed specifically via the left internal jugular vein. The investigators hypothesize that because the left internal jugular vein is anatomically more complex than the right one, tunneled dialysis catheters with split-tip design may perform sub-optimally, compared to step-tip and symmetric tip designs, when placed via the left internal jugular vein. If this hypothesis is true, the results of the study may influence future clinical practice and reduce the rates of replacement of catheters placed through the left internal jugular vein, resulting in better patient care and significant cost-savings.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 22, 2020
Est. primary completion date January 22, 2020
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: 1. Willing and able to provide a written informed consent 2. 19 years or older 3. Hemodialysis patient needing high-flow polyurethane tunneled dialysis catheter placement via the left internal jugular vein. 4. Patent left internal jugular vein. 5. Able to read and understand English. Exclusion Criteria: 1. Previous enrollment in this trial 2. Patients unable or unwilling to provide informed consent 3. Prisoners or incarcerated individuals 4. Women who are pregnant 5. Patients in whom the left internal jugular vein is occluded or catheter placement is otherwise contraindicated

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Tunneled dialysis catheter placement.
Placement of high-flow tunneled catheter for hemodialysis

Locations

Country Name City State
United States University of Akabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Complication rate 1 month complication rate of left internal jugular vein dialysis catheters 1 month
Secondary Catheter dysfunction 1 month complication rate of left internal jugular vein dialysis catheters 1 months
Secondary Catheter dysfunction 3 months complication rate of left internal jugular vein dialysis catheters 3 months
Secondary Catheter dysfunction 6 months complication rate of left internal jugular vein dialysis catheters 6 months
Secondary Complication rate 3 months complication rate of left internal jugular vein dialysis catheters 3 months
Secondary Complication rate 6 months complication rate of left internal jugular vein dialysis catheters 6 months
See also
  Status Clinical Trial Phase
Completed NCT03629496 - Developing an Arts-based Intervention for Patients With End-stage Kidney Disease Whilst Receiving Haemodialysis N/A
Completed NCT03459807 - Blood Pressure Lowering in Dialysis (BOLD) Trial Phase 2
Recruiting NCT03807583 - Plasma Amino Acid Levels After Protein Ingestion or Amino Acid Injection During Dialysis N/A
Not yet recruiting NCT03733262 - Targeted Deprescribing in Patients on Hemodialysis
Active, not recruiting NCT03934736 - HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis Phase 1